-
The characteristics of the study population are summarized in Table 1. A total of 3,079 children and adolescents with a median age of 11.4 years (IQR, 8.9–13.8 years) were included in our analysis, among whom 49.1% were girls. The majority of the participants was Han Chinese (97.7%) and lived in urban areas (84.4%). Median serum folate and vitamin B12 concentrations were 6.9 ng/mL (IQR, 4.7–9.7 ng/mL) and 554.4 pg/mL (IQR, 405.8–729.1 pg/mL), respectively. General obesity was observed in 405 participants (13.2%) and abdominal obesity was observed in 607 participants (19.7%). Generally, compared to participants without obesity, those with obesity were more likely to be boys, younger, urban residents, passive smokers, and exhibited higher hs-CRP and eGFR levels but lower vitamin B12 concentrations (Table 1).
Characteristics Total population
(n = 3,079)General obesity P-value No (n = 2,674, 86.8) Yes (n = 405, 13.2) Age (years) 11.4 (8.9, 13.8) 11.5 (8.9, 13.9) 10.4 (8.6, 13) < 0.001 Sex, n (%) < 0.001 Male 1,567 (50.9) 1,293 (48.4) 274 (67.7) Female 1,512 (49.1) 1,381 (51.6) 131 (32.3) Age group (years), n (%) 0.005 6–11 1,749 (56.8) 1,493 (55.8) 256 (63.2) 12–17 1,330 (43.2) 1,181 (44.2) 149 (36.8) Region, n (%) 0.003 Urban 2,599 (84.4) 2,237 (83.7) 362 (89.4) Rural 480 (15.6) 437 (16.3) 43 (10.6) Ethnicity, n (%) 0.521 Han ethnicity 3,009 (97.7) 2,615 (97.8) 394 (97.3) Ethnicity other than Han 70 (2.3) 59 (2.2) 11 (2.7) Lifestyle Total energy intake (kcal/day) 1,884 (1439.7, 2548.9) 1880.6 (1441.1, 2547.8) 1907.7 (1429.4, 2572.2) 0.949 Multivitamin or B-vitamin
supplements (yes), n (%)23 (0.7) 22 (0.8) 1 (0.2) 0.210 MVPA (minutes/day) 20 (8.6, 40) 20 (8.6, 40) 20 (7.9, 38.6) 0.350 Passive smoking, n (%) 0.046 Never 1,803 (58.6) 1,576 (58.9) 277 (56.0) Not daily 1,023 (33.2) 891 (33.1) 132 (32.6) Every day 253 (8.2) 207 (7.7) 46 (11.4) Alcohol consumption, n (%) 0.425 Never 2,776 (90.2) 2,404 (89.9) 372 (91.9) Former 222 (7.2) 199 (7.4) 23 (5.7) Current 81 (2.6) 71 (2.7) 10 (2.5) Anthropometrics Weight (kg) 42.0 (30.1, 54.5) 40.1 (29.1, 52.4) 56.7 (42, 74) < 0.001 Height (cm) 150.1 (135.2, 162.1) 150 (134.9, 162) 150.5 (137.7, 162.5) 0.160 BMI (kg/m2) 18.3 (16.0, 21.2) 17.6 (15.8, 20.0) 25.0 (22.0, 27.5) < 0.001 BMI-z 0.3 (−0.2, 1.0) 0.1 (−0.3, 0.7) 2.2 (1.8, 2.7) < 0.001 WC (cm) 63.4 (56.6, 71.2) 62.1 (55.8, 68.5) 79.5 (71.6, 88.1) < 0.001 WHtR 0.4 (0.4, 0.5) 0.4 (0.4, 0.5) 0.5 (0.5, 0.6) < 0.001 Abdominal obesity, n (%) 607 (19.7) 252 (9.4) 355 (87.7) < 0.001 Biochemistry Serum folate (ng/mL) 6.9 (4.7, 9.7) 6.9 (4.7, 9.8) 6.9 (5, 9.6) 0.812 Serum vitamin B12 (pg/mL) 554.4 (405.8, 729.1) 560 (408.4, 742.9) 524.7 (394.6, 676.9) 0.026 hs-CRP (mg/L) 0.3 (0.2, 0.8) 0.3 (0.2, 0.7) 0.9 (0.5, 2.2) < 0.001 eGFR (mL/min per 1.73 m2) 148.6 (135.2, 160.0) 148.0 (134.8, 159.3) 153.4 (139.1, 164) < 0.001 Note. Values are presented as median (interquartile range [IQR]) for continuous variables and n (%) for categorical variables. MVPA, total moderate-to-vigorous intensity physical activity; BMI, body mass index; BMI-z, BMI z-score; WC, waist circumference; WHtR, waist-to-height ratio; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate. P-values were calculated using the Mann-Whitney U-test for continuous variables and the chi-square test for categorical variables. Table 1. Characteristics of the participants residing in Jiangsu Province, China from 2016 to 2017
Table 2 shows the linear associations of serum folate and vitamin B12 levels with BMI, BMI-z, WC, and WHtR assessed using linear regression models. Serum vitamin B12 concentrations were inversely associated with BMI (β = −1.34, 95% CI = −1.66, −1.01, P < 0.001), BMI-z (β = −0.38, 95% CI = −0.48, −0.29, P < 0.001), WC (β = −4.50, 95% CI = −5.37, −3.63, P < 0.001) and WHtR (β = −0.023, 95% CI = −0.023, −0.018, P < 0.001) across all models. The generalized additive models demonstrated that the inverse associations of serum vitamin B12 with BMI and WC were almost roughly linear across the distribution of vitamin B12 values (Figure 2). No significant associations of serum folate with BMI, BMI-z, WC, and WHtR were identified in models 1 and 2. After additionally adjusting for serum vitamin B12 concentrations, serum folate was observed to be positively associated with WC (β = 0.80, 95% CI = 0.08, 1.52, P = 0.024) and WHtR (β = 0.004, 95% CI = 0.000, 0.009, P = 0.044). Further, the general additive model revealed a bell-shaped association between serum folate levels and BMI and an almost positive linear association between serum folate levels and WC (Figure 2). Because the association of vitamin B12 and folate with BMI z-scores was similar to that with BMI and the association with WHtR was similar to that with WC, further graphs on BMI z-scores and WHtR was not represented.
Micronutrient Model 1 Model 2 Model 3 Coefficient 95% Cl Coefficient 95% Cl Coefficient 95% Cl Serum folate (ng/mL) BMI −0.19 −0.45, 0.07 −0.23 −0.49, 0.03 0.09 −0.18, 0.35 BMI-z −0.06 −0.14, 0.01 −0.08 −0.15, 0.01 0.02 −0.06, 0.09 WC 0.39 −0.32, 1.10 −0.26 −0.96, 0.44 0.80 0.08, 1.52 WHtR 0.003 −0.001, 0.007 −0.001 −0.005, 0.003 0.004 0, 0.009 Serum vitamin B12 (pg/mL) BMI −0.83 −1.14, −0.53 −1.31 −1.61, −1.00 −1.34 −1.66, −1.01 BMI-z −0.24 −0.33, −0.15 −0.38 −0.47, −0.29 −0.38 −0.48, −0.29 WC −2.17 −3.00, −1.33 −4.23 −5.06, −3.39 −4.50 −5.37, −3.63 WHtR −0.011 −0.16, −0.006 −0.021 −0.026, −0.016 −0.023 −0.028, −0.018 Note. Model 1: adjusted for age, sex; Model 2: additionally adjusted for region, ethnicity, total energy intake, MVPA time, passive smoking status, alcohol consumption status, hs-CRP (log-transformed), eGFR (log-transformed), and multivitamin or B-vitamin supplement use. Model 3: additionally adjusted for vitamin B12(log-transformed) or serum folate (log-transformed) concentrations. MVPA, total moderate-to-vigorous intensity physical activity; BMI, Body mass index; BMI-z, BMI z-score; WC, waist circumference; WHtR, waist-to-height ratio; hs-CR, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; CI,confidence interval. Serum folate and vitamin B12 were log-transformed. Table 2. Associations of serum folate and vitamin B12 concentrations with anthropometric indices among Chinese children and adolescents in Jiangsu Province, 2016–2017 (n = 3,079)
Figure 2. Dose-response curves with 95% confidence intervals (shaded areas) representing the associations of serum folate and vitamin B12 with BMI and WC. Associations were modeled using generalized additive models (n = 3,079). Models were adjusted for age, sex, region, ethnicity, total energy intake, MVPA time, multivitamin or B-vitamin supplements use, hs-CRP (log-transformed), eGFR (log-transformed), passive smoking status, alcohol consumption status, and vitamin B12 (log-transformed) or serum folate (log-transformed) concentrations. Density plots and rug plots indicate the distributions and density of log-transformed serum folate or vitamin B12 levels. Dotted lines denote the 10th, 50th, and 90th percentiles.
As shown in Table 3, serum vitamin B12 levels were inversely associated with general obesity (OR = 0.68, 95% CI = 0.59, 0.78, P < 0.001) and abdominal obesity (OR = 0.68, 95% CI = 0.60, 0.77, P < 0.001) after adjusting for all potential confounding factors. When compared with participants in the lowest quartile, those in the highest quartile of serum vitamin B12 concentration had 71% lower odds of general obesity (OR = 0.29, 95% CI = 0.20, 0.43, P < 0.001) and 64% lower odds of abdominal obesity (OR = 0.36, 95% CI = 0.26, 0.50, P < 0.001). When evaluated as continuous exposure, no associations were observed between serum folate concentration and the odds of general and abdominal obesity. However, when compared with participants in the lowest quartile, those in the second quartile of serum folate concentration exhibited 44% higher odds of general obesity (OR = 1.44, 95% CI = 1.03, 2.00, P = 0.032) after additionally adjusting for serum vitamin B12 concentrations.
Variables Model 1 Model 2 Model 3 OR (95% CI) OR (95% CI) OR (95% CI) Serum folate General obesity Continuous 0.96 (0.85, 1.08) 0.92 (0.81, 1.05) 1.02 (0.89, 1.17) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 1.17 (0.86, 1.60) 1.26 (0.91, 1.72) 1.44 (1.03, 2.00) Q3 1.00 (0.72, 1.39) 1.03 (0.73, 1.46) 1.22 (0.86, 1.74) Q4 0.91 (0.64, 1.28) 0.84 (0.58, 1.21) 1.08 (0.74, 1.59) P-trend 0.348 0.163 0.941 Abdominal obesity Continuous 0.98 (0.88, 1.09) 0.90 (0.81, 1.01) 1.00 (0.89, 1.13) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 1.06 (0.82, 1.38) 1.05 (0.80, 1.39) 1.21 (0.91, 1.60) Q3 0.90 (0.68, 1.18) 0.82 (0.61, 1.10) 0.98 (0.72, 1.32) Q4 0.94 (0.71, 1.25) 0.79 (0.58, 1.07) 1.02 (0.74, 1.40) P-trend 0.426 0.047 0.685 Serum vitamin B12 General obesity Continuous 0.82 (0.73, 0.93) 0.68 (0.60, 0.78) 0.68 (0.59, 0.78) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 0.90 (0.67, 1.21) 0.72 (0.53, 0.99) 0.72 (0.52, 0.99) Q3 0.79 (0.58, 1.08) 0.61 (0.44, 0.86) 0.61 (0.43, 0.85) Q4 0.46 (0.32, 0.65) 0.29 (0.2, 0.43) 0.29 (0.20, 0.43) P-trend < 0.001 < 0.001 < 0.001 Abdominal obesity Continuous 0.83 (0.75, 0.92) 0.68 (0.61, 0.76) 0.68 (0.60, 0.77) Q1 1.00 (ref.) 1.00 (ref.) 1.00 (ref.) Q2 0.86 (0.67, 1.11) 0.67 (0.51, 0.87) 0.67 (0.51, 0.88) Q3 0.83 (0.64, 1.08) 0.63 (0.47, 0.83) 0.63 (0.47, 0.85) Q4 0.56 (0.42, 0.75) 0.36 (0.26, 0.49) 0.36 (0.26, 0.50) P-trend < 0.001 < 0.001 < 0.001 Note. The quartiles of serum folate concentration were as follows: < 4.7 ng/mL (Q1), 4.7–6.8 (Q2), 6.9–9.6 (Q3), and ≥ 9.7 (Q4). The quartiles of serum vitamin B12 concentrations were as follows: < 405.4 pg/mL (Q1), 405.4–554.1 (Q2), 554.2–728.8 (Q3), and ≥ 728.9 (Q4). Model 1: adjusted for age, sex; Model 2: additionally adjusted for region, ethnicity, total energy intake, MVPA time, passive smoking status and alcohol consumption status, hs-CRP (log-transformed), eGFR (log-transformed) and multivitamin or B-vitamin supplements use; Model 3: additionally adjusted for vitamin B12 (log-transformed) or serum folate (log-transformed) concentrations. MVPA, total moderate-to-vigorous intensity physical activity; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate; OR, odds ratio; CI, confidence interval. Serum folate and vitamin B12 levels were log-transformed and standardized by subtracting the mean and dividing it by the standard deviation. Table 3. Multivariable associations of serum folate and vitamin B12 levels with odds of general obesity and abdominal obesity among children and adolescents in Jiangsu Province, from 2016 to 2017 (n = 3,079)
We further evaluated the potential interaction between serum concentrations of folate and vitamin B12 using logistic regression analysis (Table 4). Participants with high concentrations of both folate and vitamin B12 (the highest quartile for each vitamin) had lower odds of general (OR = 0.31, 95% CI = 0.19, 0.50, P < 0.001) and abdominal obesity (OR = 0.46, 95% CI = 0.31, 0.67, P < 0.001) compared with those with moderate levels of both vitamins. Conversely, low serum vitamin B12 concentrations in combination with high serum folate concentrations were positively associated with higher odds of abdominal obesity (OR = 2.06, 95% CI = 1.09, 3.91, P = 0.026). Higher odds of general obesity were observed only for low serum vitamin B12 concentrations in combination with moderate serum folate concentrations (OR = 1.63, 95% CI = 1.11, 2.40, P = 0.012). Additionally, we observed a trend towards reduced odds of general (P-trend < 0.001) and abdominal obesity (P-trend < 0.001) with increased serum folate and vitamin B12 levels (data not shown). Conversely, a trend toward indicating high odds of abdominal obesity was observed with increased serum folate levels accompanied by low vitamin B12 levels (P-trend = 0.001) (data not shown).
Serum folate Serum vitamin B12 Low Moderate High General obesity Low 1.13 (0.74, 1.72) 0.80 (0.53, 1.21) 0.63 (0.27, 1.49) Moderate 1.63 (1.11, 2.40) 1.00 (ref.) 0.51 (0.34, 0.77) High 1.60 (0.75, 3.41) 0.93 (0.65, 1.34) 0.31 (0.19, 0.50) Abdominal obesity Low 1.43 (1.00, 2.03) 0.94 (0.66, 1.33) 0.77 (0.37, 1.59) Moderate 1.50 (1.07, 2.11) 1.00 (ref.) 0.60 (0.42, 0.85) High 2.06 (1.09, 3.91) 0.96 (0.70, 1.32) 0.46 (0.31, 0.67) Note. The categories “low” “moderate” and “high” serum folate levels were based to quartiles and defined as follows: ≤ 4.7 ng/mL (Q1), 4.8–9.7 ng/mL (Q2 and Q3) and > 9.8 ng/mL (Q4), respectively. The categories “low” “moderate” and “high” serum vitamin B12 levels were based to quartiles (Q) and defined as follows: ≤ 405.4 pg/mL (Q1), 405.4–728.7 ng/mL (Q2 and Q3) and > 728.8 ng/mL (Q4), respectively. Model adjusted for age, sex, region, ethnicity, total energy intake, MVPA time, multivitamin or B-vitamin supplement use, hs-CRP level (log-transformed), eGFR (log-transformed), passive smoking status, and alcohol consumption status.MVPA, total moderate-to-vigorous intensity physical activity; hs-CRP, high-sensitivity C-reactive protein; eGFR, estimated glomerular filtration rate. Table 4. Joint association of serum folate and vitamin B12 levels with general obesity and abdominal obesity among Chinese children and adolescents in Jiangsu Province, from 2016 to 2017 (n = 3,079)
Association of Serum Folate and Vitamin B12 Concentrations with Obesity in Chinese Children and Adolescents
doi: 10.3967/bes2024.028
- Received Date: 2023-06-13
- Accepted Date: 2023-10-08
-
Key words:
- Folate /
- Vitamin B12 /
- Childhood obesity /
- Micronutrient
Abstract:
This study was conducted in accordance with the Declaration of Helsinki and approved by the Ethics Committee of the National Institute for Nutrition and Health, Chinese Center for Disease Control and Prevention (protocol code: 2016-14; date of approval: January 2016). Informed consent was obtained from all the participants involved in the study.
Citation: | ZHU Qian Rang, KOK E Dieuwertje, BEKELE Hailu Tesfaye, MANUSAMA Koen, ZHANG Jing Xian, XIE Wei, ZONG Wen Qi, ZUO Hui, ZHANG Jian, KAMPMAN Ellen, DAI Yue. Association of Serum Folate and Vitamin B12 Concentrations with Obesity in Chinese Children and Adolescents[J]. Biomedical and Environmental Sciences, 2024, 37(3): 242-253. doi: 10.3967/bes2024.028 |